About Us
Leading the Way as the Fastest Growing Indo-American Company Across Six Nations
Hendrix Pharmaceuticals is the Indo-American based company with WHO-GMP & FDA approved. ISO 9001-2015 standards along International Accredited Forum Registration (IAF).
We are the largest and fastest growing pharmaceutical company in the seven other countries like India, Gulf Countries cooperation (GCC), United Kingdom (London), Canada (Ontario), United States of America (USA), Africa & Australia
Dr. Peter Cornelious
It is a pleasure to introduce Dr. Peter, a distinguished serial entrepreneur in the global healthcare industry. He is the Founder and CEO of Hendrix Medical Group of Companies (HMGC), which includes Hendrix Pharmaceuticals, a multinational pharmaceutical company specializing in drug development, clinical analysis, and international marketing. He is also associated with Cynord Cancer Centre, renowned for its advanced CAR-T cell therapy and bone marrow transplant (BMT) units.
Dr. Peter earned a Master of Science in Clinical Service Operations from Harvard Medical School, Boston, USA. With extensive expertise in human clinical trials, Clinical SAS, and Regulatory Affairs, he began his career in 2017 as a Drug Safety Associate at Vigilare Biopharma. Later, he served as a Medical Officer for Phase 3 trials on tuberculosis and the Covaxin Emergency Use Authorization in collaboration with ICMR and Mediciti Hospitals, successfully managing TB trials involving 1,200 volunteers.
Currently, as a Senior Regulatory Affairs Specialist, Dr. Peter oversees regulatory submissions for USFDA, LATAM, EMA, and ROW markets, ensuring compliance with global standards. His meticulous approach ensures the accuracy and timely delivery of critical documents, solidifying his reputation as a leader in the field.
Dr. Peter’s entrepreneurial vision, innovative thinking, and willingness to take calculated risks are complemented by his unwavering passion and commitment to new ventures. He fosters an optimistic and collaborative leadership style, driving the company’s long-term strategy while engaging with board members, associates, and stakeholders. His exceptional ability to build strong relationships with international shareholders has led to substantial investments, job creation, and opportunities for healthcare and medical professionals worldwide.
At Hendrix Pharmaceuticals, we are delighted to introduce Munawar Khan as our Managing Director. With a Master’s degree in Business Analytics from the renowned University of East London, Munawar Khan combines deep analytical expertise with visionary leadership to steer the company toward new heights.
Mr. Khan’s career is defined by his unwavering dedication to innovation, operational excellence, and patient-centric solutions. His academic foundation in business analytics empowers him to utilise cutting-edge data-driven strategies, ensuring Hendrix Pharmaceuticals remains a leader in delivering high-quality and affordable healthcare solutions.
As the Managing Director, Munawar Khan is committed to fostering growth, building strong global partnerships, and leading the organisation in its mission to transform lives through groundbreaking pharmaceutical advancements. His leadership reflects a perfect balance of innovation and integrity, driving the company toward a promising future.
Munawar
Ms Sharjeel
Hendrix Pharmaceuticals is proud to introduce Ms. Sharjeel, a dynamic leader with a passion for innovation and excellence in the pharmaceutical industry. With a Master’s degree in Business Analytics from the prestigious University of North Texas,
Ms. Sharjeel brings a unique blend of analytical expertise and strategic vision to the organisation.
As the Managing Director of Hendrix Pharmaceuticals, Ms. Sharjeel is committed to driving sustainable growth, fostering innovation, and delivering high-quality healthcare solutions. His leadership is characterised by a forward-thinking approach, leveraging data-driven insights to make impactful decisions that enhance patient care and advance the company’s mission.
He worked very closely with major healthcare and Pharmaceuticals, His deliverance of work was truly amazing, that’s his fine grip in the United states of America.
Under his guidance, Hendrix Pharmaceuticals is poised to expand its reach, strengthen its partnerships, and continue its legacy of excellence in the pharmaceutical sector.
Head-Dept of Clinical Pharmacology & Clinical Research, Medical Advisor at Hendrix Pharma
Research and Academic Experience: He has 6 years of research experience
Research Area: Clinical Trails, Post marketing Trails, In-ward observational studies
Number of Published papers: He published 17 National and international journal of repute and contributed for 4 books in medical field
Any other remarkable point(s): He is working as an Editorial Board member for American Journal of Clinical & Experimental Research. He is the reviewer in “Journal of Medical Case Reports and in “World Journal of Pharmaceutical Sciences”. He is as Certified “Antibiotic
Stewardship HCP” from Stanford university school of Medicine, California, United States
He also received ICU Management” certification from Harvard Medical School, Boston, United States. He pursued Professional Diploma in Clinical Research (PDCR) which led for Clinical trials in Covid-19 pandemic and mentored for many academic projects in clinical pharmacology and Medical Advisor for Hendrix Pharma, one of the leading Pharma in (India, Dubai, London, Canada, USA & Australia)
He is a Guest Lecture for Urban Medical Academy-Digital Course (UMA-DC) His interest in business driven him to purse his master in Business in DPU & Health business Analytics from reputed institute of India that is Indian School of Business. His dream & vision towards research profession made him evolve from Job Seeker to Jobs Creator.
